Home > Income Statement > ORCHID PHARMA

ORCHID PHARMA
Consolidated Net Profit

    Back to Income Statement
AD     Remove this Ad

ORCHID PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹100 Cr₹92 Cr₹46 Cr₹-1.95 Cr₹-117 Cr

What is the latest Consolidated Net Profit of ORCHID PHARMA ?

The latest Consolidated Net Profit ratio of ORCHID PHARMA is ₹100 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹100 Cr
Mar2024₹92 Cr
Mar2023₹46 Cr
Mar2022₹-1.95 Cr
Mar2021₹-117 Cr

How is Consolidated Net Profit of ORCHID PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹100 Cr
8.13
Mar2024 ₹92 Cr
98.99
Mar2023 ₹46 Cr
Positive
Mar2022 ₹-1.95 Cr
Negative
Mar2021 ₹-117 Cr -

Compare Consolidated Net Profit of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹3,519.6 Cr -0.8% -8.3% -51.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,991.0 Cr 0.1% -3.2% -2.6% Stock Analytics
DIVIS LABORATORIES ₹162,371.0 Cr -1.5% -7.3% 2.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,229.0 Cr -1.3% -0.7% 24.4% Stock Analytics
CIPLA ₹108,441.0 Cr 1.5% -8.1% -6.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,407.0 Cr 3.2% 5.6% 3.1% Stock Analytics


ORCHID PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

-0.8%

-8.3%

-51.4%

SENSEX

2.9%

-1.1%

8.5%


You may also like the below Video Courses